259 related articles for article (PubMed ID: 30643826)
1. Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer.
Song Y; Huang Z; Kang Y; Lin Z; Lu P; Lin Q; Cai Z; Cao Y; Zhu X
Biomed Res Int; 2018; 2018():9858943. PubMed ID: 30643826
[TBL] [Abstract][Full Text] [Related]
2. The association and diagnostic value of red blood cell distribution width in colorectal cancer.
Shi C; Xie M; Li L; Li K; Hu BL
Medicine (Baltimore); 2019 May; 98(19):e15560. PubMed ID: 31083220
[TBL] [Abstract][Full Text] [Related]
3. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of increased preoperative red cell distribution width (RDW) and changes in RDW for colorectal cancer.
Lu X; Huang X; Xue M; Zhong Z; Wang R; Zhang W; Wang L; Qiao Y; Ling F; Zhang Q; Zhang Y
Cancer Med; 2023 Jun; 12(12):13361-13373. PubMed ID: 37143237
[TBL] [Abstract][Full Text] [Related]
5. Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer.
Song B; Shi P; Xiao J; Song Y; Zeng M; Cao Y; Zhu X
Sci Rep; 2020 Sep; 10(1):15717. PubMed ID: 32973271
[TBL] [Abstract][Full Text] [Related]
6. The value of red blood cell distribution width in diagnosis of patients with colorectal cancer.
Yang D; Quan W; Wu J; Ji X; Dai Y; Xiao W; Chew H; Sun Z; Li D
Clin Chim Acta; 2018 Apr; 479():98-102. PubMed ID: 29407693
[TBL] [Abstract][Full Text] [Related]
7. The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions.
Zhang X; Wu YY; Qin YY; Lin FQ
Cancer Biomark; 2024; 39(3):223-230. PubMed ID: 38217586
[TBL] [Abstract][Full Text] [Related]
8. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
[TBL] [Abstract][Full Text] [Related]
9. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
[TBL] [Abstract][Full Text] [Related]
10. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization.
Bilgin B; Sendur MAN; Hizal M; Dede DS; Akinci MB; Kandil SU; Yaman S; Yalçin A; Kiliç M; Yalçin B
J Cancer Res Ther; 2019; 15(1):54-60. PubMed ID: 30880755
[TBL] [Abstract][Full Text] [Related]
12. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of red cell distribution width (RDW) in colorectal cancer. Results from a single-center cohort on 591 patients.
Pedrazzani C; Tripepi M; Turri G; Fernandes E; Scotton G; Conci S; Campagnaro T; Ruzzenente A; Guglielmi A
Sci Rep; 2020 Jan; 10(1):1072. PubMed ID: 31974409
[TBL] [Abstract][Full Text] [Related]
14. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer.
Huang J; Zhao Y; Liao L; Liu S; Lu S; Wu C; Wei C; Xu S; Zhong H; Liu J; Guo Y; Zhang S; Gao F; Tang W
Biomed Res Int; 2019; 2019():9852782. PubMed ID: 31467924
[TBL] [Abstract][Full Text] [Related]
16. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
17. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
18. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
20. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer.
Cheng S; Han F; Wang Y; Xu Y; Qu T; Ju Y; Lu Z
BMC Gastroenterol; 2017 Dec; 17(1):163. PubMed ID: 29262773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
